Skip to main content
 

Exosome Diagnostics is developing a clinically validated, urine-based liquid biopsy test for prostate cancer. The test is being designed to non-invasively and accurately predict high-grade prostate cancer with the goal of enabling numerous men to avoid unnecessary biopsies.

More Info & Fact Sheet